Clinical trialNCT00000940CompletedPhase 2Interventional

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment121HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will determine what effect taking a combination of five anti-HIV drugs during the early stage of HIV infection, then temporarily stopping them once or twice, may have on the amount of HIV virus in the blood (viral load). The study will also evaluate the safety and effectiveness of this anti-HIV drug combination.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Elizabeth Connick, MD
Infectious Disease Division, University of Colorado Health Sciences Center
Study Chair
clinicaltrials.gov ↗
Paul Volberding, MD
San Francisco Veterans Medical Center
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucla Care Center Crs
Los Angeles, California, United States
Usc Crs
Los Angeles, California, United States
Ucsd, Avrc Crs
San Diego, California, United States
Ucsf Aids Crs
San Francisco, California, United States
University of Colorado Hospital Crs
Aurora, Colorado, United States
Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii, United States
Massachusetts General Hospital Actg Crs
Boston, Massachusetts, United States
Sstar, Family Healthcare Ctr.
Fall River, Massachusetts, United States
Washington U Crs
St Louis, Missouri, United States
Beth Israel Med. Ctr. Actu
New York, New York, United States
Columbia P&s Crs
New York, New York, United States
Ny Univ. Hiv/aids Crs
New York, New York, United States
Aids Care Crs
Rochester, New York, United States
Mccree Mcculler Wellness Ctr. at the Connection, Infectious Disease Unit
Rochester, New York, United States
Univ. of Rochester Actg Crs
Rochester, New York, United States
Unc Aids Crs
Chapel Hill, North Carolina, United States
Hosp. of the Univ. of Pennsylvania Crs
Philadelphia, Pennsylvania, United States
the Miriam Hosp. Actg Crs
Providence, Rhode Island, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Abacavir →AmprenavirLamivudine →Ritonavir →Stavudine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 1999
Primary completion: —
Completion: 31 Oct 2006
Last update posted: 29 Oct 2021
Registered enrollment: 121
Registry id: NCT00000940

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.